| [1] |
Liodaki E, Kalousis K, Mauss KL, et al. Epidemiology of pneumonia in a burn care unit: the influence of inhalation trauma on pneumonia and of pneumonia on burn mortality[J].Ann Burns Fire Disasters，2015, 28(2)：128-133.
|
| [2] |
Galeiras R．Smoke inhalation injury：a narrative review[J]. Mediastinum, 2021，5：16.
|
| [3] |
Charles WN，Collins D，Mandalia S，et al.Impact of inhalation injury on outcomes in critically ill burns patients: 12-year experience at a regional burns centre[J].Burns，2022，48(6)：1386-1395.
|
| [4] |
Younan D, Griffin R, Zaky A, et al. Burn patients with infection-related ventilator associated complications have worse outcomes compared to those without ventilator associated events[J].Am J Surg，2018, 215(4)：678-681.
|
| [5] |
Costa Santos D，Barros F，Gomes N，et al.The effect of comorbidities and complications on the mortality of burned patients[J]. Ann Burns Fire Disasters，2017, 30(2)：103-106.
|
| [6] |
Marcut L, Manescu Paltanea V, Antoniac A, et al. Antimicrobial solutions for endotracheal tubes in prevention of ventilator-associated pneumonia[J]. Materials (Basel)，2023，16(14)：5034.
|
| [7] |
Belay CM，Zewale TA，Amlak BT，et al.Incidence and predictors of ventilator-associated pneumonia among adult intubated patients in bahir dar specialized hospitals, 2021: a retrospective follow-up study[J]. Int J Gen Med，2022，15：8173-8182.
|
| [8] |
Duek OS，Ben Naftali Y，Bar-Lavie Y，et al.Pneumonia risk in urgently intubated burn patients[J].Isr Med Assoc J，2018，20(12)：737-740.
|
| [9] |
伍迪，向阳. 黏液纤毛清除系统在呼吸道疾病中的作用[J].中南大学学报(医学版)，2023，48(2)：275-284.
|
| [10] |
Andrani F，Aiello M，Bertorelli G，et al. Cough, a vital reflex. mechanisms, determinants and measurements[J].Acta Biomed，2019，89(4)：477-480.
|
| [11] |
Luo J，Guo GH.Interpretation for practice guidelines for prevention, diagnosis, and treatment of ventilator-associated pneumonia in burn patients by american burn association[J].Burns Trauma，2015，3：11.
|
| [12] |
Kuznetsova TA, Andryukov BG, Besednova NN. Modern aspects of burn injury immunopathogenesis and prognostic immunobiochemical markers (mini-review)[J].BioTech (Basel)，2022，11(2)：18.
|
| [13] |
Laggner M, Lingitz MT, Copic D, et al. Severity of thermal burn injury is associated with systemic neutrophil activation[J].Sci Rep，2022, 12(1)：1654.
|
| [14] |
Korkmaz HI，Flokstra G，Waasdorp M, et al. The complexity of the post-burn immune response: an overview of the associated local and systemic complications[J].Cells，2023，12(3)：345.
|
| [15] |
Moins-Teisserenc H, Cordeiro DJ, Audigier V, et al. Severe altered immune status after burn injury is associated with bacterial infection and septic shock[J]. Front Immunol, 2021, 12：586195.
|
| [16] |
Keykha A，Ramezani M，Amini S, et al.Oropharyngeal decontamination for prevention of vap in patients admitted to intensive care units: a systematic review[J].J Caring Sci，2021，11(3)：178-187.
|
| [17] |
Zhao T，Wu X，Zhang Q, et al. Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia[J]. Cochrane Database Syst Rev，2020，12(12)：CD008367.
|
| [18] |
Zha S，Niu J，He Z，et al.Prophylactic antibiotics for preventing ventilator-associated pneumonia: a pairwise and Bayesian network meta-analysis[J].Eur J Med Res，2023，28(1)：348.
|
| [19] |
Huzar TF, Cross JM. Ventilator-associated pneumonia in burn patients: a cause or consequence of critical illness？[J]. Expert Rev Respir Med, 2011，5(5)：663-673.
|
| [20] |
Kalil AC，Metersky ML，Klompas M，et al.Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of america and the american thoracic society[J].Clin Infect Dis, 2016, 63(5)：e61-e111.
|
| [21] |
Leone M, Bouadma L, Bouhemad B, et al. Brief summary of French guidelines for the prevention, diagnosis and treatment of hospital-acquired pneumonia in ICU[J].Ann Intensive Care，2018，8(1)：104.
|
| [22] |
Torres A，Niederman MS，Chastre J，et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European respiratory society (ERS), European society of intensive care medicine (ESICM), European society of clinical microbiology and infectious diseases (ESCMID) and asociación latinoamericana del tórax (ALAT)[J]. Eur Respir J, 2017, 50(3)：1700582.
|
| [23] |
Mosier MJ，Pham TN.American burn association practice guidelines for prevention, diagnosis, and treatment of ventilator-associated pneumonia (VAP) in burn patients[J].J Burn Care Res，2009, 30(6)：910-928.
|
| [24] |
Bouglé A, Tuffet S, Federici L, et al. Comparison of 8 versus 15 days of antibiotic therapy for pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial[J]. Intensive Care Med，2022，48(7)：841-849.
|
| [25] |
Chastre J, Luyt CE.Does this patient have VAP？[J].Intensive Care Med, 2016，42(7)：1159-1163.
|
| [26] |
Kisat M, Zarzaur B. Antibiotic therapy in the intensive care unit[J]. Surg Clin North Am，2022，102(1)：159-167.
|
| [27] |
Papazian L, Klompas M，Luyt CE.Ventilator-associated pneumonia in adults: a narrative review[J].Intensive Care Med，2020，46(5)：888-906.
|
| [28] |
Ackerman BH，Reigart CL，Stair-Buchmann M，et al.Use of nebulized antimicrobial agents in burned and mechanically ventilated patients with persistent acinetobacter baumannii，pseudomonas aeruginosa，or enterobacteriacea[J].Burns，2013，39(5)：885-891.
|
| [29] |
Jung YJ，Kim EJ，Choi YH.Aerosolized antibiotics in the treatment of hospital-acquired pneumonia/ventilator-associated pneumonia[J]. Korean J Intern Med，2022，37(1)：1-12.
|
| [30] |
Gorham J, Taccone FS, Hites M. How to use nebulized antibiotics in severe respiratory infections[J].Antibiotics (Basel)，2023，12(2)：267.
|
| [31] |
Tang R, Luo R，Wu B，et al. Effectiveness and safety of adjunctive inhaled antibiotics for ventilator-associated pneumonia：a systematic review and meta-analysis of randomized controlled trials[J].J Crit Care，2021，65：133-139.
|
| [32] |
罗月，黎宁．严重烧伤患者早期肠内营养治疗的研究进展[J]. 中华烧伤杂志，2021，37(9)：880-884.
|
| [33] |
瞿介明，施毅．中国成人医院获得性肺炎与呼吸机相关性肺炎诊断和治疗指南(2018年版)[J]. 中华结核和呼吸杂志，2018, 41(4)：244-246.
|
| [34] |
Wise AK，Hromatka KA，Miller KR.Energy expenditure and protein requirements following burn injury[J].Nutr Clin Pract，2019, 34(5)：673-680.
|
| [35] |
Yang B，Cai YQ，Wang XD.The impact of diabetes mellitus on mortality and infection outcomes in burn patients: a meta-analysis[J].Eur Rev Med Pharmacol Sci，2021，25(6)：2481-2492.
|
| [36] |
Yildiz-Pekoz A，Ozsoy Y．Inhaled heparin: therapeutic efficacy and recent formulations[J].J Aerosol Med Pulm Drug Deliv，2017，30(3)：143-156.
|
| [37] |
Lan X, Huang Z, Tan Z，et al.Nebulized heparin for inhalation injury in burn patients: a systematic review and meta-analysis[J].Burns Trauma. 2020，8：tkaa015.
|
| [38] |
Miller AC，Elamin EM, Suffredini AF.Inhaled anticoagulation regimens for the treatment of smoke inhalation-associated acute lung injury: a systematic review[J].Crit Care Med，2014，42(2)：413-419.
|
| [39] |
Phelps MK, Olson LM, Patel MAVB，et al. Nebulized heparin for adult patients with smoke inhalation injury: a review of the literature[J]. J Pharm Techno，2020，36(4)：130-140.
|
| [40] |
中国老年医学学会烧创伤分会. 吸入性损伤临床诊疗全国专家共识(2018版)[J]. 中华烧伤杂志，2018，34(11)770-775.
|
| [41] |
蒋勇，王康安，王宝丽，等. 266例合并烧伤总面积小于30%体表总面积的吸入性损伤患者的流行病学特征及结局分析[J].中华烧伤杂志，2021，37(4)：340-349.
|
| [42] |
申传安．危重烧伤救治新技术体系[M].北京：人民卫生出版社，2021.
|
| [43] |
Bittner E, Sheridan R．Acute respiratory distress syndrome, mechanical ventilation, and inhalation injury in burn patients[J].Surg Clin North Am，2023，103(3)：439-451.
|
| [44] |
Milton-Jones H，Soussi S，Davies R, et al.An international RAND/UCLA expert panel to determine the optimal diagnosis and management of burn inhalation injury[J].Crit Care，2023，27(1)：459.
|
| [45] |
孙丹，赵朋，倪佳莹，等．气道管理小组在群体严重烧伤合并吸入性损伤患者救治中的作用[J]. 中华烧伤杂志，2018，34(6)：354-359.
|
| [46] |
王淑君，马春亭，鲁虹言，等．成批烧伤患者肺部护理集束化管理方案的构建与应用[J].中华烧伤杂志，2020，36(8)：665-670.
|
| [47] |
Pozuelo-Carrascosa DP，Herráiz-Adillo Á，Alvarez-Bueno C, et al. Subglottic secretion drainage for preventing ventilator-associated pneumonia: an overview of systematic reviews and an updated meta-analysis[J].Eur Respir Rev，2020，29(155)：190107.
|
| [48] |
Zand F，Zahed L，Mansouri P，et al.The effects of oral rinse with 0.2% and 2% chlorhexidine on oropharyngeal colonization and ventilator associated pneumonia in adults' intensive care units[J].J Crit Care, 2017，40：318-322.
|
| [49] |
Dale CM，Rose L，Carbone S，et al.Effect of oral chlorhexidine de-adoption and implementation of an oral care bundle on mortality for mechanically ventilated patients in the intensive care unit (CHORAL): a multi-center stepped wedge cluster-randomized controlled trial[J].Intensive Care Med，2021，47(11)：1295-1302.
|
| [50] |
Li HY，Wang HS，Wang YL，et al. Management of ventilator-associated pneumonia: quality assessment of clinical practice guidelines and variations in recommendations on drug therapy for prevention and treatment[J].Front Pharmacol，2022，13：903378.
|
| [51] |
O′Keefe-McCarthy S，Santiago C，Lau G．Ventilator-associated pneumonia bundled strategies: an evidence-based practice[J].Worldviews Evid Based Nurs，2008，5(4)：193-204.
|
| [52] |
Saint S, Greene MT，Fowler KE，et al. What US hospitals are currently doing to prevent common device-associated infections: results from a national survey[J].BMJ Qual Saf，2019，28(9)：741-749.
|
| [53] |
柏愚，李延青，任旭，等．应激性溃疡防治专家建议(2018版)[J].中华医学杂志，2018, 98(42)：3392-3395.
|